Published • loading... • Updated
Creative Biolabs Introduces Human In Vitro Models to Advance Neuro-Research
- Creative Biolabs uses human iPSC-derived neural models, microglial phagocytosis assays, and automated organ-on-chip platforms to address challenges in neurotherapeutic drug discovery.
- The high failure rate of neurotherapeutic candidates is partly due to reliance on animal models and simple two-dimensional cell cultures.
- Creative Biolabs provides interconnected in vitro solutions to create more accurate disease models and improve therapeutic evaluation.
- Their approach includes physiologically relevant human iPSC-derived neural models, microglia phagocytosis assays, and advanced organ-on-chip platforms with automated fluid handling.
Insights by Ground AI
42 Articles
42 Articles
Napa Valley Register+41 Reposted by 41 other sources
Creative Biolabs Introduces Human In Vitro Models to Advance Neuro-Research
Creative Biolabs addresses translational bottlenecks in drug discovery by integrating human iPSC-derived neural models, specialized microglial phagocytosis assays, and automated organ-on-chip platforms to create predictive human-centric neuro-environments.
Coverage Details
Total News Sources42
Leaning Left8Leaning Right4Center23Last UpdatedBias Distribution66% Center
Bias Distribution
- 66% of the sources are Center
66% Center
L 23%
C 66%
11%
Factuality
To view factuality data please Upgrade to Premium
